The Physics-AI Dialogue in Drug Design
RSC Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 1, 2025
A
long
path
has
led
from
the
determination
of
first
protein
structure
in
1960
to
recent
breakthroughs
science.
Protein
prediction
and
design
methodologies
based
on
machine
learning
(ML)
have
been
recognized
with
2024
Nobel
prize
Chemistry,
but
they
would
not
possible
without
previous
work
input
many
domain
scientists.
Challenges
remain
application
ML
tools
for
structural
ensembles
their
usage
within
software
pipelines
by
crystallography
or
cryogenic
electron
microscopy.
In
drug
discovery
workflow,
techniques
are
being
used
diverse
areas
such
as
scoring
docked
poses,
generation
molecular
descriptors.
As
become
more
widespread,
novel
applications
emerge
which
can
profit
large
amounts
data
available.
Nevertheless,
it
is
essential
balance
potential
advantages
against
environmental
costs
deployment
decide
if
when
best
apply
it.
For
hit
lead
optimization
efficiently
interpolate
between
compounds
chemical
series
free
energy
calculations
dynamics
simulations
seem
be
superior
designing
derivatives.
Importantly,
complementarity
and/or
synergism
physics-based
methods
(e.g.,
force
field-based
simulation
models)
data-hungry
growing
strongly.
Current
evolved
decades
research.
It
now
necessary
biologists,
physicists,
computer
scientists
fully
understand
limitations
ensure
that
exploited
design.
Language: Английский
A thermodynamic cycle to predict the competitive inhibition outcomes of an evolving enzyme
bioRxiv (Cold Spring Harbor Laboratory),
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 7, 2025
Abstract
Understanding
competitive
inhibition
at
the
molecular
level
is
essential
for
unraveling
dynamics
of
enzyme-inhibitor
interactions
and
predicting
evolutionary
outcomes
resistance
mutations.
In
this
study,
we
present
a
framework
linking
to
alchemical
free
energy
perturbation
(FEP)
calculations,
focusing
on
E.
coli
dihydrofolate
reductase
(DHFR)
its
by
trimethoprim
(TMP).
Using
thermodynamic
cycles,
relate
experimentally
measured
binding
constants
(
K
i
m
)
differences
associated
with
wild-type
mutant
forms
DHFR
mean
error
0.9
kcal/mol,
providing
insights
into
underpinnings
TMP
resistance.
Our
findings
highlight
importance
local
conformational
in
inhibition.
Mutations
affect
substrate
inhibitor
affinities
differently,
influencing
fitness
landscape
under
selective
pressure
from
TMP.
FEP
simulations
reveal
that
mutations
stabilize
inhibitor-bound
or
substrate-bound
states
through
specific
structural
and/or
dynamical
effects.
The
interplay
these
effects
showcases
significant
epistasis
certain
cases.
ability
separately
assess
provides
valuable
insights,
allowing
more
precise
interpretation
mutation
epistatic
interactions.
Furthermore,
identify
key
challenges
simulations,
including
convergence
issues
arising
charge-changing
long-range
allosteric
By
integrating
computational
experimental
data,
provide
an
effective
approach
functional
impact
their
contributions
landscapes.
These
pave
way
constructing
robust
mutational
scanning
protocols
designing
therapeutic
strategies
against
resistant
bacterial
strains.
Language: Английский
Covalent-Allosteric Inhibitors: Do We Get the Best of Both Worlds?
Hui Tao,
No information about this author
Bo Yang,
No information about this author
Atena Farhangian
No information about this author
et al.
Journal of Medicinal Chemistry,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 12, 2025
Covalent-allosteric
inhibitors
(CAIs)
may
achieve
the
best
of
both
worlds:
increased
potency,
long-lasting
effects,
and
reduced
drug
resistance
typical
covalent
ligands,
along
with
enhanced
specificity
decreased
toxicity
inherent
in
allosteric
modulators.
Therefore,
CAIs
can
be
an
effective
strategy
to
transform
many
undruggable
targets
into
druggable
ones.
However,
are
challenging
design.
In
this
perspective,
we
analyze
discovery
known
targeting
three
protein
families:
phosphatases,
kinases,
GTPases.
We
also
discuss
how
computational
methods
tools
play
a
role
addressing
practical
challenges
rational
CAI
Language: Английский
Discovery of Novel Pyridin-2-yl Urea Inhibitors Targeting ASK1 Kinase and Its Binding Mode by Absolute Protein–Ligand Binding Free Energy Calculations
Lingzhi Wang,
No information about this author
Yalei Gao,
No information about this author
Yuying Chen
No information about this author
et al.
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(4), P. 1527 - 1527
Published: Feb. 12, 2025
Apoptosis
signal-regulating
kinase
1
(ASK1),
a
key
component
of
the
mitogen-activated
protein
(MAPK)
cascades,
has
been
identified
as
promising
therapeutic
target
owing
to
its
critical
role
in
signal
transduction
pathways.
In
this
study,
we
proposed
novel
pyridin-2-yl
urea
inhibitors
exhibiting
favorable
physicochemical
properties.
The
potency
these
compounds
was
validated
through
vitro
bioassays.
inhibition
(IC50)
compound
2
1.55
±
0.27
nM,
which
comparable
known
clinical
inhibitor,
Selonsertib.
To
further
optimize
hit
compounds,
two
possible
binding
modes
were
initially
predicted
by
molecular
docking.
Absolute
free
energy
(BFE)
calculations
based
on
dynamics
simulations
discriminated
modes,
presenting
good
tendency
with
bioassay
results.
This
strategy,
underpinned
BFE
calculations,
great
potential
expedite
drug
discovery
process
targeting
ASK1
kinase.
Language: Английский
FEP-SPell-ABFE: An Open-Source Automated Alchemical Absolute Binding Free-Energy Calculation Workflow for Drug Discovery
Pengfei Li,
No information about this author
Tianlei Pu,
No information about this author
Ye Mei
No information about this author
et al.
Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 3, 2025
The
binding
affinity
between
a
drug
molecule
and
its
target,
measured
by
the
absolute
free
energy
(ABFE),
is
crucial
factor
in
lead
discovery
phase
of
development.
Recent
research
has
highlighted
potential
silico
ABFE
predictions
to
directly
aid
development
allowing
for
ranking
prioritization
promising
candidates.
This
work
introduces
an
open-source
Python
workflow
called
FEP-SPell-ABFE,
designed
automate
calculations
with
minimal
user
involvement.
requires
only
three
key
inputs:
receptor
protein
structure
PDB
format,
candidate
ligands
SDF
configuration
file
(config.yaml)
that
governs
both
molecular
dynamics
simulation
parameters.
It
produces
ranked
list
along
their
energies
comma-separated
values
(CSV)
format.
leverages
SLURM
(Simple
Linux
Utility
Resource
Management)
automating
task
execution
resource
allocation
across
modules.
A
usage
example
several
benchmark
systems
validation
are
provided.
FEP-SPell-ABFE
workflow,
practical
example,
publicly
accessible
on
GitHub
at
https://github.com/freeenergylab/FEP-SPell-ABFE,
distributed
under
MIT
License.
Language: Английский
QuantumBind-RBFE: Accurate Relative Binding Free Energy Calculations Using Neural Network Potentials
Journal of Chemical Information and Modeling,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 8, 2025
Accurate
prediction
of
protein-ligand
binding
affinities
is
crucial
in
drug
discovery,
particularly
during
hit-to-lead
and
lead
optimization
phases,
however,
limitations
ligand
force
fields
continue
to
impact
accuracy.
In
this
work,
we
validate
relative
free
energy
(RBFE)
accuracy
using
neural
network
potentials
(NNPs)
for
the
ligands.
We
utilize
a
novel
NNP
model,
AceFF
1.0,
based
on
TensorNet
architecture
small
molecules
that
broadens
applicability
diverse
drug-like
compounds,
including
all
important
chemical
elements
supporting
charged
molecules.
Using
established
benchmarks,
show
overall
improved
correlation
affinity
predictions
compared
with
GAFF2
molecular
mechanics
ANI2-x
NNPs.
Slightly
less
but
comparable
correlations
OPLS4.
also
can
run
simulations
at
2
fs
time
step,
least
two
times
larger
than
previous
models,
providing
significant
speed
gains.
The
results
promise
further
evolutions
calculations
NNPs
while
demonstrating
its
practical
use
already
current
generation.
code
model
are
publicly
available
research
use.
Language: Английский
Enhancing the understandings on SARS-CoV-2 main protease (Mpro) mutants from molecular dynamics and machine learning
Jiawen Wang,
No information about this author
Juan Xie,
No information about this author
Yi Yu
No information about this author
et al.
International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 143076 - 143076
Published: April 1, 2025
Language: Английский
A Thermodynamic Cycle to Predict the Competitive Inhibition Outcomes of an Evolving Enzyme
Journal of Chemical Theory and Computation,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 23, 2025
Understanding
competitive
inhibition
at
the
molecular
level
is
essential
for
unraveling
dynamics
of
enzyme-inhibitor
interactions
and
predicting
evolutionary
outcomes
resistance
mutations.
In
this
study,
we
present
a
framework
linking
to
alchemical
free
energy
perturbation
(FEP)
calculations,
focusing
on
Escherichia
coli
dihydrofolate
reductase
(DHFR)
its
by
trimethoprim
(TMP).
Using
thermodynamic
cycles,
relate
experimentally
measured
binding
constants
(Ki
Km)
differences
associated
with
wild-type
mutant
forms
DHFR
mean
error
0.9
kcal/mol,
providing
insight
into
underpinnings
TMP
resistance.
Our
findings
highlight
importance
local
conformational
in
inhibition.
Mutations
affect
substrate
inhibitor
affinities
differently,
influencing
fitness
landscape
under
selective
pressure
from
TMP.
FEP
simulations
reveal
that
mutations
stabilize
inhibitor-bound
or
substrate-bound
states
through
specific
structural
and/or
dynamical
effects.
The
interplay
these
effects
showcases
significant
molecular-level
epistasis
certain
cases.
ability
separately
assess
provides
valuable
insights,
allowing
more
precise
interpretation
mutation
epistatic
interactions.
Furthermore,
identify
key
challenges
simulations,
including
convergence
issues
arising
charge-changing
long-range
allosteric
By
integrating
computational
experimental
data,
provide
an
effective
approach
functional
impact
their
contributions
landscapes.
These
insights
pave
way
constructing
robust
mutational
scanning
protocols
designing
therapeutic
strategies
against
resistant
bacterial
strains.
Language: Английский